The invention relates to triamide MTP/ApoB inhibitors of the formula 1
##STR1##
wherein R1-R8 are as defined in the specification,
as well as pharmaceutical compositions and uses thereof, and processes for preparing
the compounds. The compounds of the invention are useful for the treatment of obesity
and lipid disorders.
